Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.

6 clinical trials · Sponsor

Record	Firm	Date
FHND1002 for ALS Treatment: Phase 2 (NCT07138014)	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.	2025-10-01
Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal Conditions (NCT06762743)	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.	2024-10-21
Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults (NCT06782958)	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.	2024-07-05
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of FHND5071 as a Single Agent in Adult Patients With Advanced Solid Tumors (NCT05818917)	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.	2022-07-07
A Study Evaluating Safety, Tolerability and Clinical Activity of FHND6091 in Patients With Multiple Myeloma (NCT05271682)	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.	2021-12-22
FHND9041 Versus Afatinib for Non-small Cell Lung Cancer (NCT06759857)	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.	2021-08-01

Every clearance here is in the API, with alerts when new ones post.